Singapore markets open in 40 minutes

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.2500+0.0400 (+3.31%)
At close: 04:00PM EDT
1.2589 +0.01 (+0.71%)
After hours: 07:11PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-34,968
-32,485
-32,947
376
-18,210
-
Depreciation & amortisation
80
67
145
178
180
-
Stock-based compensation
4,223
4,202
4,884
5,054
3,600
-
Change in working capital
799
720
11,236
-15,343
1,122
-
Accounts receivable
-
-220
10,420
-10,869
1,893
-
Other working capital
-20,489
-19,912
-13,611
-10,733
-13,175
-
Other non-cash items
9,597
9,361
3,284
-
188
230
Net cash provided by operating activities
-18,770
-18,135
-13,365
-10,733
-13,120
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,719
-1,777
-246
-
-55
-25
Purchases of investments
-
-
-
-
0
0
Sales/maturities of investments
-
-
-
0
0
32,950
Net cash used for investing activities
-1,719
-1,777
-246
0
-55
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-5,340
-5,000
Common stock issued
15,681
1,666
566
23,283
11,958
-
Other financing activities
10,319
-1,350
30,638
-
-
10,319
Net cash used provided by (used for) financing activities
14,425
414
31,333
23,782
7,867
-
Net change in cash
-6,064
-19,498
17,722
13,049
-5,308
-
Cash at beginning of period
41,419
48,418
30,696
17,647
22,955
-
Cash at end of period
35,355
28,920
48,418
30,696
17,647
-
Free cash flow
Operating cash flow
-18,770
-18,135
-13,365
-10,733
-13,120
-
Capital expenditure
-1,719
-1,777
-246
-
-55
-25
Free cash flow
-20,489
-19,912
-13,611
-10,733
-13,175
-